| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,970 |
7,042 |
$4.92M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
7,298 |
6,510 |
$3.81M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,046 |
9,096 |
$3.75M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,249 |
1,129 |
$2.36M |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
5,818 |
5,382 |
$862K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,750 |
3,335 |
$728K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,257 |
1,162 |
$677K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,650 |
1,514 |
$376K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
4,768 |
4,160 |
$372K |
| 71046 |
Radiologic examination, chest; 2 views |
1,590 |
1,499 |
$365K |
| 71045 |
Radiologic examination, chest; single view |
2,881 |
2,552 |
$361K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,746 |
1,556 |
$196K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,488 |
3,018 |
$186K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
961 |
866 |
$182K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
70 |
67 |
$178K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,947 |
2,558 |
$172K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
513 |
423 |
$135K |
| J3490 |
Unclassified drugs |
22,348 |
11,183 |
$127K |
| 80053 |
Comprehensive metabolic panel |
12,061 |
10,455 |
$113K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,071 |
10,320 |
$103K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
590 |
395 |
$94K |
| 36415 |
Collection of venous blood by venipuncture |
13,129 |
11,506 |
$79K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
237 |
217 |
$73K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
93 |
88 |
$72K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
2,486 |
2,286 |
$70K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
39 |
39 |
$62K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
734 |
513 |
$51K |
| 83880 |
|
1,783 |
1,631 |
$50K |
| 81025 |
|
4,024 |
3,586 |
$39K |
| 81001 |
|
9,189 |
8,163 |
$35K |
| 84484 |
|
3,550 |
2,735 |
$34K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
518 |
460 |
$33K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
16 |
12 |
$28K |
| 71250 |
|
66 |
65 |
$26K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
439 |
359 |
$26K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
13 |
13 |
$24K |
| 83690 |
|
2,441 |
2,207 |
$19K |
| 85730 |
|
2,858 |
2,584 |
$15K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
70 |
65 |
$13K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
586 |
528 |
$12K |
| 85610 |
|
2,892 |
2,625 |
$10K |
| 83605 |
|
788 |
686 |
$9K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
683 |
611 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
441 |
351 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
180 |
170 |
$3K |
| 83735 |
|
489 |
411 |
$3K |
| J2704 |
Injection, propofol, 10 mg |
258 |
201 |
$3K |
| 84145 |
|
171 |
150 |
$3K |
| 85027 |
|
384 |
341 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
866 |
774 |
$3K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,977 |
1,673 |
$2K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
45 |
12 |
$2K |
| A9270 |
Non-covered item or service |
4,538 |
1,364 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
142 |
117 |
$1K |
| 80076 |
|
108 |
95 |
$927.55 |
| 86140 |
|
152 |
144 |
$899.31 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
26 |
26 |
$885.24 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
26 |
26 |
$885.20 |
| 81003 |
|
199 |
170 |
$658.72 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
54 |
43 |
$533.43 |
| 85007 |
|
126 |
117 |
$489.59 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
163 |
116 |
$448.99 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
82 |
72 |
$444.37 |
| 82962 |
|
143 |
82 |
$341.99 |
| 85651 |
|
72 |
68 |
$293.10 |
| 82550 |
|
44 |
41 |
$265.59 |
| 87040 |
|
21 |
12 |
$245.60 |
| 87077 |
|
26 |
24 |
$226.85 |
| 85379 |
|
12 |
12 |
$201.60 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
39 |
29 |
$198.18 |
| 87081 |
|
27 |
27 |
$179.57 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
18 |
16 |
$156.91 |
| 81002 |
|
64 |
41 |
$156.91 |
| J1790 |
Injection, droperidol, up to 5 mg |
13 |
12 |
$141.85 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
16 |
13 |
$113.28 |
| 87210 |
|
12 |
12 |
$64.71 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
15 |
14 |
$24.24 |